Page last updated: 2024-11-04

sumatriptan and Reperfusion Injury

sumatriptan has been researched along with Reperfusion Injury in 4 studies

Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.

Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.

Research Excerpts

ExcerptRelevanceReference
"This study demonstrated that sumatriptan has protective effects against mesenteric ischemia and the kynurenine inhibition is potentially involved in this process."8.31Low-dose sumatriptan improves the outcome of acute mesenteric ischemia in rats via downregulating kynurenine. ( Ala, M; Asl Soleimani, M; Dehpour, AR; Fallahpour Khoshdel, MR; Goudarzi, S; Mohammad Jafari, R; Sadrkhanloo, M, 2023)
"This study demonstrated that sumatriptan has protective effects against mesenteric ischemia and the kynurenine inhibition is potentially involved in this process."4.31Low-dose sumatriptan improves the outcome of acute mesenteric ischemia in rats via downregulating kynurenine. ( Ala, M; Asl Soleimani, M; Dehpour, AR; Fallahpour Khoshdel, MR; Goudarzi, S; Mohammad Jafari, R; Sadrkhanloo, M, 2023)
"Pre-treatment with sumatriptan decreased 5-hydroxytryptamine (5HT) level by 53%, and significantly decreased calcitonin gene-related peptide (CGRP) levels, lipid pereoxidation, neutrophil infiltration, and level of pro-inflammatory markers in the serum."1.56Involvement of 5-HT1B/1D receptors in the inflammatory response and oxidative stress in intestinal ischemia/reperfusion in rats. ( Abdollahi, A; Dehpour, AR; Gharishvandi, F; Mohammad Jafari, R; Pasalar, P; Shafaroodi, H, 2020)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's4 (100.00)2.80

Authors

AuthorsStudies
Ala, M1
Fallahpour Khoshdel, MR1
Mohammad Jafari, R3
Sadrkhanloo, M1
Goudarzi, S1
Asl Soleimani, M1
Dehpour, AR4
Mobasheran, P1
Rajai, N1
Kohansal, P1
Shafaroodi, H3
Gharishvandi, F2
Abdollahi, A2
Pasalar, P2

Other Studies

4 other studies available for sumatriptan and Reperfusion Injury

ArticleYear
Low-dose sumatriptan improves the outcome of acute mesenteric ischemia in rats via downregulating kynurenine.
    Pharmacological reports : PR, 2023, Volume: 75, Issue:3

    Topics: Animals; Ischemia; Kynurenine; Mesenteric Ischemia; Rats; Reperfusion Injury; Sumatriptan; Tumor Nec

2023
The effects of acute sumatriptan treatment on renal ischemia/reperfusion injury in rat and the possible involvement of nitric oxide.
    Canadian journal of physiology and pharmacology, 2020, Volume: 98, Issue:4

    Topics: Acute Kidney Injury; Animals; Blood Urea Nitrogen; Creatinine; Kidney; Male; Malondialdehyde; Nitric

2020
Involvement of 5-HT1B/1D receptors in the inflammatory response and oxidative stress in intestinal ischemia/reperfusion in rats.
    European journal of pharmacology, 2020, Sep-05, Volume: 882

    Topics: Animals; Calcitonin Gene-Related Peptide; Ileum; Inflammation; Intestinal Mucosa; Male; Mesenteric I

2020
The protective effect of α7-nACh receptor and its interaction with 5-HT1B/1D receptors in acute intestinal ischemia-reperfusion injury in rats.
    Fundamental & clinical pharmacology, 2022, Volume: 36, Issue:1

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Rats; Receptor, Serotonin, 5-HT1B; Receptor, Serot

2022